AuntMinnie

JULY 12, 2024

As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. A shortage of nuclear medicine technologists means a theranostics center may need to limit its patient volume.

Nuclear Medicine 105

Nuclear Medicine Radiation Oncology Radiopharmaceuticals Radiation 105

AuntMinnie

MARCH 7, 2024

In 2023 compared with 2022, the total volume of positron emission tomography (PET) scans increased 10.2% In 2023, the average number of PET scans per fixed PET site (versus mobile PET) increased 6.7% from 1,401 estimated PET scans per system in 2022 to 1,495 in 2023. Davin Korstjens. physicians reading PET scans per site.

PET Scan 116

PET Scan Nuclear Medicine Radiation Oncology Radiopharmaceuticals 116

Imaging Technology

JANUARY 2, 2024

26-30, 2023.

Radiologic Technology 94

Radiologic Technology Radiation Oncology Nuclear Medicine Radiology 94

AuntMinnie

APRIL 4, 2024

Even if some private urology, radiation oncology practices, or radiologist groups are building the ability to perform theranostics, experts are cautious about patient management, radiation safety, and the risk of unnecessary imaging. However, few freestanding theranostics centers exist today. Hope added.

Nuclear Medicine 88

Nuclear Medicine Radiation Oncology Nursing Radiation 88

AuntMinnie

JULY 10, 2024

The organization noted that the CMS expects the overall impact of the proposed MPFS to be neutral on radiology, nuclear medicine, and radiation oncology. However, interventional radiology will have a decrease of 2%. In the rule, the CMS estimates a 2025 conversion factor of $32.36

Medicare 105

Medicare Radiation Oncology Nuclear Medicine Radiation 105

AuntMinnie

MARCH 26, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. The nuclear radiologist, nuclear medicine technologist, and radiation safety team are all present to administer an infusion.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

AuntMinnie

JUNE 20, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. The nuclear radiologist, nuclear medicine technologist, and radiation safety team are all present to administer an infusion.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52